Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Update on Cyberdyne (7779 JP) & Short Sellers - FDA Application for HAL With New Wording

Cyberdyne has resubmitted its 2015 Fda Application for its medical-use HAL saying, this time, that it is a "cybernic [sic] treatment device" that attempts to improve a patient's own physical functions rather than a robot or device to Assist Walking. The difference in definition is subtle but important, because there is no implication in the new application that the device is guaranteed to assist walking. As a consequence, HAL only needs to show that it could assist walking. The...(continued)

This insight is part of Smartkarma. For more follow this link.



This post first appeared on Smartkarma | Intelligent Investing, please read the originial post: here

Share the post

Update on Cyberdyne (7779 JP) & Short Sellers - FDA Application for HAL With New Wording

×

Subscribe to Smartkarma | Intelligent Investing

Get updates delivered right to your inbox!

Thank you for your subscription

×